annalise.ai Receives FDA Clearance and Breakthrough Device Designation

Annalise Enterprise CTB now CE marked as class IIb and approved for clinical use in Europe

Obsessed with the process.

Employee Spotlight: Luci Temple – Software Engineer

Press release: annalise.ai grows global footprint with expansion into India

annalise.ai Announces FDA 510(k) Clearance for Four Non-contrast Head CT Findings

annalise.ai Announces FDA 510(k) Clearance for Additional CXR Findings

Press release: annalise.ai Builds Momentum in U.S. Market with Seven Additional FDA-Cleared Findings for Imaging Triage and Notification

annalise.ai wins ‘Best New Radiology Vendor’ in prestigious Minnies Awards

annalise.ai receives Great Place to Work recognition